Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/qSYP9v0rydM


We look at 5 robotic surgery stocks that have a market cap greater than $100 million. Accuracy deals in radiation so isn't robotic surgery in the strictest sense of the term. Stereotaxis isn't enjoying revenue growth, so they're not worth pursuing until that happens. Globus Medical is hardly a pure play, while Procept BioRobotics doesn't seem to have as large an opportunity as they think. That brings us to Intuitive Surgical ISRG which is a leader in surgical robotics and certainly worth a closer look - at the right valuation that is.

Ver todos los episodios